EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Differential effects of subcutaneous and sublingual immunotherapy on timothy grass–specific TH2 CD4+ T-cell subsets

Hannah A DeBerg, Carolyn H Baloh, Quinn DeGottardi, Jue Hou, Alexandra Johansson, Evan Newell, Tanya M Laidlaw, Srinath Sanda, Mohamed Shamji, Stephen Durham, Alkis Togias, William W Kwok

Journal of Allergy and Clinical Immunology · 2026

DOI: 10.1016/j.jaci.2026.02.026 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026. Verfasst von Hannah A DeBerg und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Systems Immunology, Benaroya Research Institute (BRI) at Virginia Mason, Seattle, Wash. Hauptthemen laut MEDLINE: Phleum, Th2 Cells, Desensitization, Immunologic, Allergens. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Allergen-specific CD4+ T cells are a highly heterogenous population. Depletion of these cells has been proposed as essential to achieve allergen desensitization in allergen immunotherapy. OBJECTIVE: The overall aim of this study was to characterize the heterogeneity of timothy grass (Phleum pratense) allergen-specific CD4+ T cells and determine how the frequency and phenotype of these cells change in response to sublingual (SLIT) and subcutaneous (SCIT) immunotherapy. Correlations between frequencies of these cells with Total Nasal Symptom Score and grass-specific serum immunoglobulin were also investigated. METHODS: Mass cytometry with lanthanides-tagged peptide major histocompatibility complex class II multimers and CD154 upregulation assays were used to examine changes in the frequency and phenotype of Phl p-specific CD4+ T cells in longitudinal peripheral blood mononuclear cell samples from a randomized, double-blind, placebo-controlled trial of SLIT and SCIT. Supervised and unsupervised clustering was used for data analysis. RESULTS: Phenotypes of Phl p-specific T cells were highly heterogenous but could be categorized into two major metaclusters, CRTH2hiCD27lo and CRTH2loCD27hi, each with distinct phenotypic profiles. Weak positive correlations between Total Nasal Symptom Score and frequencies of T cells within both subsets were observed. SCIT preferentially depleted CRTH2hiCD27lo cells, whereas SLIT depleted CRTH2loCD27hi cells. CRTH2hiCD27lo cell frequency correlated with Phl p-specific IgE and IgG4, but not IgA, levels. CONCLUSION: Unsupervised clustering revealed distinct subpopulations of allergen-specific T cells that were differentially targeted and depleted by SCIT and SLIT, suggesting that SCIT and SLIT act through overlapping but distinct immunologic pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhleumTh2 CellsDesensitization, ImmunologicAllergensSublingual ImmunotherapyRhinitis, Allergic, SeasonalT-Lymphocyte SubsetsCD4-Positive T-LymphocytesHumansFemaleMaleInjections, SubcutaneousImmunoglobulin EAdultPlant Proteins

Stichwörter der Autor:innen

Allergic rhinitisallergen immunotherapyantigen-specific T cellsgrass allergygrass immunotherapygrass-specific T cellsmultimer positive T cells

Substanzen

AllergensImmunoglobulin EPlant Proteins

Autor:innen und Institutionen

  • Center for Systems Immunology, Benaroya Research Institute (BRI) at Virginia Mason, Seattle, Wash.
  • Immune Tolerance Network, BRI at Virginia Mason, Seattle, Wash; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Mass.
  • Center for Translational Immunology, BRI at Virginia Mason, Seattle, Wash; Seattle Children's Research Institute, Seattle, Wash.
  • Center for Translational Immunology, BRI at Virginia Mason, Seattle, Wash; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Wash.
  • Center for Translational Immunology, BRI at Virginia Mason, Seattle, Wash.
  • Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Wash.

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

DeBerg, H. A., Baloh, C. H., DeGottardi, Q., Hou, J., Johansson, A., Newell, E., Laidlaw, T. M., Sanda, S., Shamji, M., Durham, S., Togias, A., & Kwok, W. W. (2026). Differential effects of subcutaneous and sublingual immunotherapy on timothy grass–specific TH2 CD4+ T-cell subsets. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2026.02.026

Vancouver

DeBerg HA, Baloh CH, DeGottardi Q, Hou J, Johansson A, Newell E, et al. Differential effects of subcutaneous and sublingual immunotherapy on timothy grass–specific TH2 CD4+ T-cell subsets. Journal of Allergy and Clinical Immunology. 2026. doi:10.1016/j.jaci.2026.02.026

BibTeX
@article{DeBerg2026,
  author = {DeBerg, Hannah A and Baloh, Carolyn H and DeGottardi, Quinn and Hou, Jue and Johansson, Alexandra and Newell, Evan and Laidlaw, Tanya M and Sanda, Srinath and Shamji, Mohamed and Durham, Stephen and Togias, Alkis and Kwok, William W},
  title = {Differential effects of subcutaneous and sublingual immunotherapy on timothy grass–specific TH2 CD4+ T-cell subsets},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2026},
  doi = {10.1016/j.jaci.2026.02.026}
}
Kostenlos starten →